(Q43080796)

English

Rifaximin for inflammatory bowel disease

scientific article published in June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Rifaximin for inflammatory bowel disease (English)

1 reference

Europe PubMed Central

13 November 2017

inflammatory bowel diseases

1 reference

based on heuristic

inferred from title

author name string

Mario Guslandi

1

1 reference

Europe PubMed Central

13 November 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

13 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

13 November 2017

55

1 reference

Europe PubMed Central

13 November 2017

6

1 reference

Europe PubMed Central

13 November 2017

1805

1 reference

Europe PubMed Central

13 November 2017

https://scigraph.springernature.com/pub.10.1007/s10620-010-1245-y

0 references

Mucosal flora in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifaximin and Crohn's disease: a new solution to an old problem?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifaximin for active ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysbiosis in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroid-sparing effect of rifaximin, a nonabsorbable oral antibiotic, in active ulcerative colitis: Preliminary clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/20428944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-010-1245-Y

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43080796&oldid=1980473870"